1 | 1 | | MISSISSIPPI LEGISLATURE 2025 Regular Session To: Insurance By: Senator(s) Wiggins Senate Bill 2400 AN ACT TO REQUIRE EACH INDIVIDUAL OR GROUP HEALTH INSURANCE POLICY OR PLAN THAT IS DELIVERED OR RENEWED ON OR AFTER JULY 1, 2025, TO OFFER COVERAGE FOR CLINICAL GENETIC TESTING FOR AN INHERITED GENE MUTATION FOR INDIVIDUALS WITH A PERSONAL OR FAMILY HISTORY OF CANCER THAT IS RECOMMENDED BY A HEALTHCARE PROFESSIONAL, AND EVIDENCED-BASED CANCER IMAGING FOR INDIVIDUALS WITH AN INCREASED RISK OF CANCER AS RECOMMENDED BY NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINES; AND FOR RELATED PURPOSES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: SECTION 1. (1) In this section the following terms have the meanings indicated: (a) Cost-sharing requirements means a deductible, coinsurance, copayment, or any similar out-of-pocket expense. (b) Evidenced-based cancer imaging means evidence-based cancer imaging modalities in accordance with the most recent version of the National Comprehensive Cancer Network (NCCN) clinical practice guidelines. (c) Genetic testing for an inherited mutation means germline multi-gene testing for an inherited mutation associated with an increased risk of cancer in accordance with evidence-based, clinical practice guidelines. (2) Any group health plan, or a health insurance issuer offering group or individual health insurance regulated by the State of Mississippi that is delivered, issued for delivery, or renewed on or after July 1, 2025, shall include coverage for: (i.) Clinical genetic testing for an inherited gene mutation for individuals with a personal or family history of cancer that is recommended by a healthcare professional; and (ii.) Evidenced-based cancer imaging for individuals with an increased risk of cancer as recommended by NCCN clinical practice guidelines. (3) Coverage required by this section shall not be subject to cost-sharing requirements. (4) If under federal law, application of this section would result in Health Savings Account ineligibility under Section 223 of the federal Internal Revenue Code, this requirement shall apply only, for Health Savings Account-qualified High Deductible Health Plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under Section 223, except for with respect to items or services that are preventive care pursuant to Section 223(c)(2)(C) of the federal Internal Revenue Code, in which case the requirements of subsection (1) shall apply regardless of whether the minimum deducible under Section 223 has been satisfied. SECTION 2. This act shall take effect and be in force from and after July 1, 2025. |
---|
2 | 2 | | |
---|
3 | 3 | | MISSISSIPPI LEGISLATURE |
---|
4 | 4 | | |
---|
5 | 5 | | 2025 Regular Session |
---|
6 | 6 | | |
---|
7 | 7 | | To: Insurance |
---|
8 | 8 | | |
---|
9 | 9 | | By: Senator(s) Wiggins |
---|
10 | 10 | | |
---|
11 | 11 | | # Senate Bill 2400 |
---|
12 | 12 | | |
---|
13 | 13 | | AN ACT TO REQUIRE EACH INDIVIDUAL OR GROUP HEALTH INSURANCE POLICY OR PLAN THAT IS DELIVERED OR RENEWED ON OR AFTER JULY 1, 2025, TO OFFER COVERAGE FOR CLINICAL GENETIC TESTING FOR AN INHERITED GENE MUTATION FOR INDIVIDUALS WITH A PERSONAL OR FAMILY HISTORY OF CANCER THAT IS RECOMMENDED BY A HEALTHCARE PROFESSIONAL, AND EVIDENCED-BASED CANCER IMAGING FOR INDIVIDUALS WITH AN INCREASED RISK OF CANCER AS RECOMMENDED BY NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINES; AND FOR RELATED PURPOSES. |
---|
14 | 14 | | |
---|
15 | 15 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: |
---|
16 | 16 | | |
---|
17 | 17 | | SECTION 1. (1) In this section the following terms have the meanings indicated: |
---|
18 | 18 | | |
---|
19 | 19 | | (a) Cost-sharing requirements means a deductible, coinsurance, copayment, or any similar out-of-pocket expense. |
---|
20 | 20 | | |
---|
21 | 21 | | (b) Evidenced-based cancer imaging means evidence-based cancer imaging modalities in accordance with the most recent version of the National Comprehensive Cancer Network (NCCN) clinical practice guidelines. |
---|
22 | 22 | | |
---|
23 | 23 | | (c) Genetic testing for an inherited mutation means germline multi-gene testing for an inherited mutation associated with an increased risk of cancer in accordance with evidence-based, clinical practice guidelines. |
---|
24 | 24 | | |
---|
25 | 25 | | (2) Any group health plan, or a health insurance issuer offering group or individual health insurance regulated by the State of Mississippi that is delivered, issued for delivery, or renewed on or after July 1, 2025, shall include coverage for: |
---|
26 | 26 | | |
---|
27 | 27 | | (i.) Clinical genetic testing for an inherited gene mutation for individuals with a personal or family history of cancer that is recommended by a healthcare professional; and |
---|
28 | 28 | | |
---|
29 | 29 | | (ii.) Evidenced-based cancer imaging for individuals with an increased risk of cancer as recommended by NCCN clinical practice guidelines. |
---|
30 | 30 | | |
---|
31 | 31 | | (3) Coverage required by this section shall not be subject to cost-sharing requirements. |
---|
32 | 32 | | |
---|
33 | 33 | | (4) If under federal law, application of this section would result in Health Savings Account ineligibility under Section 223 of the federal Internal Revenue Code, this requirement shall apply only, for Health Savings Account-qualified High Deductible Health Plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under Section 223, except for with respect to items or services that are preventive care pursuant to Section 223(c)(2)(C) of the federal Internal Revenue Code, in which case the requirements of subsection (1) shall apply regardless of whether the minimum deducible under Section 223 has been satisfied. |
---|
34 | 34 | | |
---|
35 | 35 | | SECTION 2. This act shall take effect and be in force from and after July 1, 2025. |
---|